Skin Effector Memory T Cells Do Not Recirculate and Provide Immune Protection in Alemtuzumab-Treated CTCL Patients

High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma

(2010) R. A. Clark et al.   BLOOD

Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors

(2010) J. J. Campbell et al.   BLOOD

Current and Emerging Treatment Strategies for Cutaneous T-cell Lymphoma

(2010) Frederick Lansigan et al.   DRUGS

Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer Center

(2010) Christiane Querfeld et al.   LEUKEMIA & LYMPHOMA

Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models

(2010) William M. Siders et al.   LEUKEMIA & LYMPHOMA

Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell–mediated immunity

(2010) Luzheng Liu et al.   NATURE MEDICINE

Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model

(2009) Yanping Hu et al.   IMMUNOLOGY

Skin-Resident T Cells: The Ups and Downs of On Site Immunity

(2009) Rachael A. Clark   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus

(2009) Thomas Gebhardt et al.   NATURE IMMUNOLOGY

Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome

(2008) R. van Doorn et al.   BLOOD

Characteristics and stage of the underlying diseases could determine the risk of opportunistic infections in patients receiving alemtuzumab

(2008) A. Nosari et al.   HAEMATOLOGICA

Fatal adenoviral and enteroviral infections and an Epstein-Barr virus positive large B-cell lymphoma after alemtuzumab treatment in a patient with refractory Sézary syndrome

(2008) Nathalie Roch et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Subcutaneous alemtuzumab for Sézary Syndrome in the very elderly

(2007) Lapo Alinari et al.   LEUKEMIA RESEARCH